Cprr chemistry and immunoassay
Ended Awarded Last action
- Contract number
- N6809422F6004
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $482,006
Award facts
- Contract value 100% obligated
- $482,006.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $241,003 | |
| Original award | $241,003 |
About this award
The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal healthcare agency to access Roche's diagnostic capabilities through pre-negotiated terms.
Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, is a primary supplier of in vitro diagnostic equipment, analyzers, and reagents to federal healthcare agencies. The company maintains an extensive portfolio of Defense Health Agency contracts totaling over $20 million across multiple indefinite delivery vehicles and blanket purchase agreements, providing molecular diagnostics, clinical chemistry analysis, immunochemistry testing, and comprehensive laboratory support services to military and civilian healthcare systems. This delivery order represents one component of Roche's sustained partnership with the Defense Health Agency to supply advanced diagnostic testing capabilities to support military healthcare operations.
Quick answers
Who was awarded contract N6809422F6004?
N6809422F6004 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on May 1, 2022.
How much is contract N6809422F6004 worth?
The government has obligated $482,006 on N6809422F6004.
Is contract N6809422F6004 an order under another contract?
Yes. N6809422F6004 is a delivery order under V797P7347A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract N6809422F6004 competed?
The extent of competition for N6809422F6004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award